Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography
about
Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic WindowNeuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivityImaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopyThalamic glutamate decreases with cigarette smokingTargeting glutamate homeostasis for potential treatment of nicotine dependence.In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat modelThe role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human Positron Emission Tomography (PET) studies.The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study.Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688Neuroimaging in Alcohol and Drug DependenceMetabotropic glutamate receptor 5 - a promising target in drug development and neuroimaging.Metabotropic glutamate receptor 5 as a potential target for smoking cessation.Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression.N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis.Withdrawal from cocaine self-administration and yoked cocaine delivery dysregulates glutamatergic mGlu5 and NMDA receptors in the rat brain.Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans.Quantitative positron emission tomography of mGluR5 in rat brain with [(18) F]PSS232 at minimal invasiveness and reduced model complexity.Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder.Effects of the Positive Allosteric Modulator of Metabotropic Glutamate Receptor 5, VU-29, on Impairment of Novel Object Recognition Induced by Acute Ethanol and Ethanol Withdrawal in Rats.A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5.Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder.Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy.Development of PET and SPECT probes for glutamate receptors.Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study
P2860
Q26775243-ED4DB4E9-85DA-48F3-8E79-CBB24F34AFEBQ31031649-62F6A821-BE1F-4535-9260-F70E19AD1381Q33930038-F1AFFE60-5B4F-4735-B21E-159716DCA3DEQ34276587-02CEDD66-C41A-4DDF-B0F2-80805B48C2F7Q34502468-97CFF082-10C7-4A90-BCB3-B1E8DFBAE6E6Q34778858-D7B4511B-1394-47D2-9D76-A5F5479E96CFQ35129804-4800E844-8F7E-4CD4-B0EB-994040ED9593Q35190052-16C1ED61-EA2B-43B5-B463-7EB063AE8CD3Q36248846-A41B14F6-CFFD-406F-824F-44662C0CC368Q37347468-81F665E3-D137-4C2C-B4B7-8580A16B3259Q37657596-3C18536C-12C5-4801-B730-5928A9260BC1Q38690069-AC2DE180-476E-4D3E-9AE0-11C2C8D8E9C1Q38795082-4D8A1403-7290-4539-939D-7C13FE514108Q41468480-E993B362-735F-48A4-9665-A7815053738BQ41994846-B9A8435B-3E1E-4312-B890-6516B1859216Q43076061-75DE2FA9-C24F-4C4B-9A77-DF486F8D0256Q43180906-1E9D72EC-87B8-42AF-B083-18358820B2F0Q45332980-B6D16602-674C-41F6-B88C-39313E51E984Q46828950-154FB29D-D951-45D5-AE4F-2F79E6DBC838Q47215698-2526EEAD-9D47-45F4-AEFC-4D77A4DF0617Q47237998-DB590471-0985-4F31-90C9-156A76DC50E0Q47695530-172AD2E7-C1EE-4C0F-8DDE-CD0059F61F58Q47823561-5152E5DB-D3DE-4D3B-980D-5EDCB91AD08CQ51834454-F47CFA09-B554-4B4F-85DA-2F5C34655066Q52600080-319089B6-5823-4D33-B91F-4AB7E88D15ABQ53015251-4DA976E1-E37D-4EBB-A871-B2CBE2FD6C43Q58213887-6382B178-F876-4F47-83E8-D0CFA8A5E6DB
P2860
Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Marked global reduction in mGl ...... 8 positron emission tomography
@ast
Marked global reduction in mGl ...... 8 positron emission tomography
@en
type
label
Marked global reduction in mGl ...... 8 positron emission tomography
@ast
Marked global reduction in mGl ...... 8 positron emission tomography
@en
prefLabel
Marked global reduction in mGl ...... 8 positron emission tomography
@ast
Marked global reduction in mGl ...... 8 positron emission tomography
@en
P2093
P2860
P356
P1476
Marked global reduction in mGl ...... 8 positron emission tomography
@en
P2093
Alfred Buck
Anass Johayem
Baltazar Gomez Mancilla
Cyrill Burger
Daniel Umbricht
Funda Akkus
Judit Sovago
Simon M Ametamey
P2860
P304
P356
10.1073/PNAS.1210984110
P407
P577
2012-12-17T00:00:00Z